Statistics: It's Essential
July 29 - August 3, 2017
Baltimore Convention Center
JSM 2017 Online Program
Legend:
CC
= Baltimore Convention Center,
H
= Hilton Baltimore
* = applied session ! = JSM meeting theme
Activity Details
Tweet
533
Wed, 8/2/2017, 12:30 PM - 1:50 PM
CC-Ballroom II
Biopharmaceutical Section P.M. Roundtable Discussion (Added Fee) — Roundtables PM Roundtable Discussion
Biopharmaceutical Section
Organizer(s): Qi Jiang, Amgen Inc.
WL08:
Aggregate Safety Monitoring for the FDA IND Safety Reporting Final Rule
—
Greg Ball, Merck
WL09:
Statistical Considerations for Rare Disease Clinical Development
—
Yang Song, Vertex Pharmaceuticals
WL10:
Statistical Inference in the Era of Precision Medicine- the Essential Role of Statistics for Unmet Needs in Algorithm Refinement, Diagnostics Application and Drug Development
—
Ruixiao Lu, Genomic Health
WL11:
Beyond the Statistical Analysis Plan: Statisticians Partaking Earlier in Design of Clinical Trials
—
Yuqun Abigail Luo, FDA
WL12:
Unblinded Sample Size Re-Estimation for Complex Trials
—
Chris Holland, Amgen